SYSTEM NOTICE

Auto translation by AI. Be sure, accuracy, nuances and authorial intent may not be fully reflected.
見出し画像

[4/12 - 4/18] Notable Large-Scale Fundraisings

The U.S. startup funding market for the second week of April 2025 (April 12–18) showed active movement across a wide range of fields, led by the AI boom, including energy, blockchain, and biotech. The total funding for the top 10 companies exceeded $2.7 billion. In particular, Safe Superintelligence (hereinafter SSI) raising $2 billion left a strong impression of the growing need for "safety" in the generative AI era. In this report, we will explain the background, technical trends, and market impact of each round, incorporating specific examples and quotes.

1. Overview of Fundraising for the Second Week of April 2025


1-1. Overview of the Top 10 Companies

Key Points

  • AI-related companies account for 4 firms / over 80% of the total funding

  • The background to the inflow of capital into energy and infrastructure is the "AI power hunger" phenomenon

  • Biotech shows signs of scaling up in both rare diseases and digital health

2. Safe Superintelligence — The biggest bet on "safe AGI"


2-1. Background: OpenAI defection and the resurgence of "AI alignment"

SSI is a research lab co-founded by former OpenAI lead researcher Ilya Sutskever. It has managed to double its funding just seven months after raising $1 billion in the fall of 2024. Sutskever stated the following at the time of the investment announcement:

"Our mission is to realize 'safe and beneficial superintelligence.' Alignment is the top priority, not scaling."

2-2. The meaning of the $32B valuation

The $32 billion market capitalization significantly exceeds that of Anthropic (around $15 billion) at a similar phase.

  • Investor goals — Capturing the uncharted territory of the "alignment market"

  • Industry impact — Acceleration of capital concentration in AI ethics and safety startups

  • Risks — As a research-focused entity before commercialization, the revenue model is a "super-long-term scenario"

3. Energy x AI: Mainspring Energy's $258M funding


3-1. Meeting data center demand with distributed generators

The linear generators supplied by Mainspring support diverse fuels such as gas, ammonia, and hydrogen, providing output in the tens of MW range.

"AI services want power 24/7. Flexible power sources to supplement grid strain are essential." (General Catalyst Partner)

3-2. Three perspectives investors are watching closely

  1. Smoothing peak demand: On-site power generation reduces electricity costs for cloud operators

  2. Compatibility with decarbonization trends: Evaluated as an ESG asset through renewable energy co-firing and hydrogen compatibility

  3. Long-term contract model: PPA + maintenance contracts boost LTV

4. Blockchain resurgence: Auradine's 153 M


4-1. Mining solutions in the ESG era

Auradine improves power efficiency with liquid-cooled ASICs and renewable energy optimization software. It also develops network chips for AI data centers to hedge against mining dependency risks.

CEO comment: "Redesigning the infrastructure for Bitcoin and AI simultaneously"

4-2. Signals of a Web3 investment restart

VCs remained on the sidelines during the 2023 'crypto winter,' but capital injection into infrastructure and B2B sectors is returning.

5. Diverse challenges in biotech


5-1. Glycomine: Moving to Phase 2b clinical trials for rare disease treatment

Glycomine specializes in ultra-rare diseases such as protein glycosylation disorders. While the market size upon success is small, cash generation through the resale of PRVs (Priority Review Vouchers) is expected.

5-2. Science: Challenging Neuralink with brain-retina interfaces

The founder is a former Neuralink engineer. With a dual pipeline of brain implants and retinal chips, they are targeting everything from "medical applications to consumer AR."

Khosla Ventures evaluates it as "human augmentation is the next moonshot."

5-3. Attovia Therapeutics: Next-generation antibody platform

Attovia rapidly generates bispecific antibodies using an automated drug discovery engine. They are targeting atopic dermatitis and autoimmune diseases with short cycles.

6. Data infrastructure and security


6-1. Hammerspace: The 'universal data fabric' for the AI era

The company's Global Data Platform provides a single namespace across multiple clouds and on-premises environments, simplifying the handling of LLM training data. The investment from Altimeter is a strategic move anticipating a post-Snowflake 'data OS'.

6‑2. Exaforce: A security agent that realizes AI SOC

By leveraging large language models and RLHF, it aims to reduce alert noise by 98% and compress analyst workload to 1/10th. A $75 million Series A is exceptionally large.

'Becoming the GitHub Copilot for security operations' — From investor presentation materials

7. Aging Society and Fintech


7‑1. Chapter: Growth potential in Medicare navigation

The U.S. population aged 65 and over is expected to approach 77 million in the next decade. Chapter claims that by combining AI bots with expert advisors, it can reduce annual insurance expenditures by an average of $750. Stripes led the investment for the second consecutive year.

7‑2. Luma Financial Technologies: A structured product platform for securities firms

With its 3rd-generation UI and API, it automates the creation and sales flow of bonds and structured products, supporting operational efficiency for mid-tier banks.

  • A new phase of the AI shift: Capital is shifting from 'performance competition' to 'safety, infrastructure, and operational efficiency'

  • Re-evaluation of energy and hardware: Generative AI's power demand is simultaneously boosting cleantech and semiconductors

  • Personalization in healthtech: 'Niche x massive markets' such as rare diseases and elderly support are running in parallel

Investors' gaze is on 'AI + X'
This week's movements indicate that AI has graduated from a single sector to a 'layer that repaints other industries.' It is highly likely that massive funding will continue at the intersection of AI and energy/bio/fintech in the coming weeks.

Finally, outside the U.S., the $200 million raised by China's Zelos stood out. Globally, the 'AI infrastructure investment race' is overheating, and an era has arrived where the 'quality of use' is becoming an evaluation axis, not just the scale of funding.


Related articles


いいなと思ったら応援しよう!

この記事は noteマネー にピックアップされました

noteマネーのバナー